<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01307254</url>
  </required_header>
  <id_info>
    <org_study_id>BAFLA</org_study_id>
    <nct_id>NCT01307254</nct_id>
  </id_info>
  <brief_title>Association Between Non-alcoholic Fatty Liver Disease and Iron Status</brief_title>
  <acronym>BAFLA</acronym>
  <official_title>(BAFLA- Barzilai Fatty Liver and Iron Metabolism Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ornit Cohen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prof Doron Zamir</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that low iron storages protects from and down-grades
      non-alcoholic fatty liver disease.

      The aim of the study is to show the association between the severity of Non-alcoholic fatty
      liver disease to low iron status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients that will pass a CT scan that includes the abdomen will be asked to participate at
      our study. These patients will be divided into two groups - with and w/o fatty liver. The
      severity of fatty liver will be determined using the CT scan (as well as other parameters,
      such as the size of subcutaneous fat layer). Within 72 hours from the scan, a venous blood
      test will be taken from the enrolled patients (together with a BMI calculation and a blood
      pressure measurements). In the blood test we will examine liver functions, iron status etc.

      This is a preliminary study that will aid in planning future strategies to treat or even
      prevent fatty liver (one of the epidemics of our century).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>grade of fatty liver disease</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>NAFLD - Non Alcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>Non alcoholic fatty liver disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood analysis</intervention_name>
    <description>A single venous blood test will be taken - 4 tubes (hematology, clotting, chemistry, sedimentation rate)</description>
    <arm_group_label>Non alcoholic fatty liver disease</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that will pass a CT scan at our institution. The scan must include the abdomen,
        with or without any contrast material.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18

          -  BMI&gt;25

        Exclusion Criteria:

          -  pregnancy

          -  unable to sign an informed consent (legally)

          -  known solid/hematological malignancy

          -  hemoglobinopathy or myelodysplastic disease (not including G6PD deficiency)

          -  active or carrier of viral hepatitis

          -  treated a drug the cause fatty liver (eg. amiodarone, tetracyclin, HAART, steroid
             treatment &gt; 3 months)

          -  consumption of &gt; 120g ethanol per week

          -  primary liver disease (eg. glycogen storage disease)

          -  CRP&gt;20

          -  acute intoxication

          -  surgery in previous 7 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Grinshpun</last_name>
    <phone>972-54-5615563</phone>
    <email>albert.grinshpun@mail.huji.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barzilai medical center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78278</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Grinshpun</last_name>
      <phone>972-54-5615563</phone>
      <email>albert.grinshpun@mail.huji.ac.il</email>
    </contact>
    <investigator>
      <last_name>Zamir Doron, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2011</study_first_submitted>
  <study_first_submitted_qc>March 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2011</study_first_posted>
  <last_update_submitted>September 19, 2012</last_update_submitted>
  <last_update_submitted_qc>September 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Barzilai Medical Center</investigator_affiliation>
    <investigator_full_name>Ornit Cohen</investigator_full_name>
    <investigator_title>r&amp;d unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

